ReviewObesity surgery2026
Comparative Outcomes of Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass in Adults with Severe Obesity: A Systematic Review and Meta-Analysis.
Review in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) is increasingly used for severe obesity, but its comparative effectiveness versus Roux-en-Y gastric bypass (RYGB) remains uncertain. This systematic review and meta-analysis included 12 comparative studies (3,317 patients) identified through searches of major databases to April 2026. Random-effects meta-analyses suggested a potential weight-loss benefit with SADI-S compared with RYGB at selected follow-up points, while no clear differences were observed in remission of type 2 diabetes, hypertension, or dyslipidemia, or in HbA1c reduction. No clear differences were observed in operative outcomes or early complications, while the findings suggested potential reductions in reoperations and selected late surgical complications with SADI-S; a nonsignificant trend toward greater calcium deficiency was also observed. Evidence certainty was predominantly low or very low because of methodological limitations and heterogeneity. Comparative mortality could not be assessed because no included study provided mortality data suitable for pooling, highlighting the need for high-quality long-term randomized studies.
Indexed as
Identifiers
42742831What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.